Atherosclerosis - PowerPoint PPT Presentation

1 / 36
About This Presentation
Title:

Atherosclerosis

Description:

Title: PowerPoint Presentation Author: Center for TeleMedicine Last modified by: Roman Komorovsky Created Date: 11/11/1999 3:59:39 PM Document presentation format – PowerPoint PPT presentation

Number of Views:158
Avg rating:3.0/5.0
Slides: 37
Provided by: CenterforT160
Category:

less

Transcript and Presenter's Notes

Title: Atherosclerosis


1
Atherosclerosis
2
Atheroma are not merely filled with lipid, but
contain cells whose functions critically
influence atherogenesis
  • Intrinsic Vascular Wall Cells
  • Endothelium
  • Smooth Muscle Cells
  • Inflammatory Cells
  • Macrophages
  • T Lymphocytes
  • Mast Cells

3
Cell Types in the Human Atheroma
Monocyte/Macrophage
Endothelium
Intima
TunicaMedia
T-lymphocytes
Smooth musclecells
4
Schematic Time Course of Human Atherogenesis
Ischemic HeartDisease
CerebrovascularDisease
Peripheral VascularDisease
Lesion initiation
No symptoms
Symptoms
Symptoms
Time (y)
5
Macrophage Functions in Atherogenesis
Attachment
6
LeukocyteEndothelial Adhesion Molecules
Mono
T
PMN
B
7
Vascular Cell Adhesion Molecule 1(VCAM-1)
  • Binds monocytes and lymphocytes- Cells found in
    atheroma
  • Expressed by endothelium over nascent fatty
    streaks
  • Expressed by microvessels of the mature atheroma

8
An atherogenic diet rapidly induces VCAM-1, a
cytokine-regulatable mononuclear leukocyte
adhesion molecule, in rabbit aortic endothelium
Li H et al. Arterioscler Thromb 199313197-204.
9
VCAM-1 Expression in Rabbit Aorta
3 weeks on atherogenic diet
Li H et al. Arterioscler Thromb 199313197-204.
10
Macrophage Functions in Atherogenesis
Penetration
11
Monocyte Chemoattractant Protein 1(MCP-1)
  • A potent mononuclear cell chemoattractant
  • Produced by endothelial and smooth muscle cells
  • Localizes in human and experimental atheroma

12
Absence of monocyte chemoattractant protein-1
reduces atherosclerosis in low-density
lipoprotein receptordeficient mice
Gu L et al. Mol Cell 19982275-281.
13
Reduced Lipid Deposition in MCP-1Deficient
Atherosclerotic Mice
LDL-R /MCP-1 /
LDL-R /MCP-1 /
Gu L et al. Mol Cell 19982275-281.
14
Reduced Lipid Deposition in MCP-1Deficient
Atherosclerotic Mice
Oil Red Staining Aortic Surface Stained


/
-/-
/
-/-
Time on Diet
12 14 weeks
20 25 weeks
P 0.001 compared to /p 0.005 compared
to /
Gu L et al. Mol Cell 19982275-281.
15
Macrophage Functions in Atherogenesis
Activation
16
Macrophage Functions in Atherogenesis
Division
17
Macrophage Colony-Stimulating Factor (M-CSF)
  • A potent monocyte activator and co-mitogen
  • Produced by endothelial and smooth muscle cells
  • Localizes in human and experimental atheroma

18
Augmented M-CSF gene expression in human and
experimental atherogenesis
Rosenfeld ME et al. Am J Pathol
1992140291-300. Clinton SK et al. Am J Pathol
1992140301-316.
19
M-CSF Expression in Atheroma
IntimalM-CSFinAtheroma
20
M-CSF Promotes Atherogenesis
Smith JD et al. Decreased atherosclerosis in
mice deficient in both macrophage
colony-stimulating factor (op) and apolipoprotein
E. Proc Natl Acad Sci U S A 1995928264-8268. Qi
ao JH et al. Role of macrophage
colony-stimulating factor in atherosclerosis
studies of osteopetrotic mice. Am J Pathol
19971501687-1699. Rajavashisth T et al.
Heterozygous osteopetrotic (op) mutation reduces
atherosclerosis in LDL receptordeficient mice. J
Clin Invest 19981012702-2710.
21
M-CSF Deficiency (op mutation) Reduces Atheroma
in LDL ReceptorKnockout Mice
/
op/
op/op
Rajavashisth T et al. J Clin Invest
19981012702-2710.
22
M-CSF Gene Dosage Relates to Atheroma Size in
LDLR / Mice
107
106
Fatty Lesions in Aortic Root(?m2/section)
105
104
103
op/
/
op/op
Genotype
Rajavashisth T et al. J Clin Invest
19981012702-2710.
23
Molecular Mediators of Atherogenesis
VCAM-1
MCP-1
M-CSF
24
Anatomy of the Atherosclerotic Plaque
Fibrous cap
Lumen
Shoulder
Lipid Core
Intima
Internal
Elastic laminæ
Media
External
25
Schematic Time Course of Human Atherogenesis
Ischemic HeartDisease
CerebrovascularDisease
Peripheral VascularDisease
Transition from chronic to acute atheroma
26
Thrombosis of a Disrupted Atheroma, the Cause of
Most Acute Coronary Syndromes, Results from
  • Weakening of the fibrous cap
  • Thrombogenicity of the lipid core

Illustration courtesy of Michael J. Davies, M.D.
27
Matrix Metabolism and Integrity of the Plaques
Fibrous Cap
Synthesis
Breakdown
Fibrouscap
Collagen-degrading Proteinases
IFN-?

CD-40L




IL-1TNF-?MCP-1M-CSF


Tissue Factor Procoagulant
Lipid core
Libby P. Circulation 1995912844-2850.
28
Increased Expression of Interstitial Collagenase
(CL) by Smooth Muscle Cells (SMC) and Macrophages
(M?) in Human Atheroma
Galis ZS et al. J Clin Invest 1994942493-2503.
29
Plaque Rupture with Thrombosis
Fibrous cap
Thrombus
1 mm
Lipid core
Illustration courtesy of Frederick J. Schoen,
M.D., Ph.D.
30
Thrombosis of a Disrupted Atheroma, the Cause of
Most Acute Coronary Syndromes, Results from
  • Weakening of the fibrous cap
  • Thrombogenicity of the lipid core

Illustration courtesy of Michael J. Davies, M.D.
31
CD40 and Tissue Factor in Atheroma
CD40
Tissue Factor
Mach F et al. Circulation 199796396-399.
32
CD40 Ligation Induces Tissue Factor Expression in
Human Monocyte-Derived Macrophages
160 120 80 40 0
160 120 80 40 0
T cell/membranes/?-CD40L
rCD40L/?-CD40L
T cell/membranes
rCD40L
Cell Numbers
100
101
102
103
100
101
102
103
Log Fluorescence
Mach F et al. Circulation 199796396-399.
33
CD40 ligand on activated platelets triggers an
inflammatory reaction of endothelial cells
Henn V et al. Nature 1998391591-594.
34
Inflammation Can Promote Thrombosis
Fibrinogen
Via gp llb/llla
TissueFactor
Platelet-FibrinThrombus
CD40L
Fibrinopeptides
35
Inflammation Participates in All Phases of
Atherothrombotic Disease
  • Lesion initiation
  • Lesion progression
  • Thrombotic complications

36
Thanks
Write a Comment
User Comments (0)
About PowerShow.com